PUBLIC COMPANY
save$OGNOrganon & Co.
$OGN13.72+0.15%Jersey City, NJ, USupdated 1d ago
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
community read0 votes
🐶 often sniffed alongside
top 8- tagRecall2 co-mentions · 2 sources
- drugNOXAFIL POWDERMIX KIT2 co-mentions · 1 sources
- drugNOXAFIL2 co-mentions · 1 sources
- drugHADLIMA2 co-mentions · 1 sources
- tagSmall Molecule1 co-mentions · 1 sources
- drugHUMIRA1 co-mentions · 1 sources
- drugPOSACONAZOLE1 co-mentions · 1 sources
- drugposaconazole DR1 co-mentions · 1 sources
pipeline
9
marketed
4
phase 3
0
catalysts ytd
13
approvals ytd
10
recalls ytd
0
Pipeline(9)
pipeline depth9 products
4Marketed5Unknown
Marketed
(betamethasone acetate + betamethasone sodium phosphate)
Cerebral Edema
Marketed(desloratadine + pseudoephedrine sulfate) ER
Nasal Congestion
MarketedPROSCAR
3-oxo-5-alpha-steroid 4-dehydrogenase 2
Marketedtocilizumab biosimilar
Coronavirus Disease 2019 (COVID-19)
drugFOSAMAX
1 INDICATIONS AND USAGE FOSAMAX PLUS D is a combination o…
Farnesyl pyrophosphate synthase
drugFOSAMAX PLUS D
1 INDICATIONS AND USAGE FOSAMAX PLUS D is a combination o…
Farnesyl pyrophosphate synthase
drugIMPLANON
HIV infection
Progesterone receptor
drugSINEMET
INDICATIONS AND USAGE SINEMET is indicated in the treatme…
Aromatic-L-amino-acid decarboxylase
drugSINEMET CR
Familial dysautonomia
Aromatic-L-amino-acid decarboxylase
Upcoming
no upcoming catalysts on record
Recent(90d)
view all catalysts →Insider activity
source: SEC Form 4routine RSU / option mechanics (6)
- Mar 31, 26tax coverWALSH MATTHEW M · Chief Financial Officer7,380 sh
- Mar 31, 26tax coverArjona Ferreira Juan Camilo · Head of R&D & CMO4,820 sh
- Mar 31, 26tax coverMorrissey Joseph T. Jr. · Interim CEO4,784 sh
- Mar 31, 26tax coverStahler Rachel A · Chief Information Officer4,217 sh
- Mar 31, 26tax coverWALSH MATTHEW M · Chief Financial Officer4,127 sh
- Mar 31, 26tax coverFalcione Aaron · Chief Human Resources Officer3,834 sh
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 12m ago
Found something off?
comments(0)
5-min edit window · permanent after that